Patents by Inventor Tom De Vringer

Tom De Vringer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120039948
    Abstract: A powder of reversed vesicles, which comprises one or more non-ionic surfactants and optionally a lipophilic stabilising factor and a bio-active agent, is provided. The product is prepared by making a dispersion of reversed vesicles in a suitable apolar vehicle, which vehicle is subsequently removed. In admixture with one or more excipients the product can be incorporated in compositions.
    Type: Application
    Filed: March 11, 2011
    Publication date: February 16, 2012
    Applicant: ASTELLAS PHARMA EUROPE B.V.
    Inventors: Tom de Vringer, Henk Mollee
  • Publication number: 20100145018
    Abstract: Lipid conjugates of a poly-(amino acid), a poly-(amino acid derivative) or a poly-(amino acid analogue), such as poly-[N-(2-hydroxyethyl)-glutamine](PHEG), are provided.
    Type: Application
    Filed: July 6, 2009
    Publication date: June 10, 2010
    Applicant: Astellas Pharma Europe BV
    Inventors: Josbert Maarten Metselaar, Wilhelmus Everardus Hennick, Tom De Vringer, Leonardus Wilhelmus Theodorus De Boer, Christien Oussoren, Gerrit Storm, Peter Bruin
  • Publication number: 20090291105
    Abstract: A powder of reversed vesicles, which comprises one or more non-ionic surfactants and optionally a lipophilic stabilising factor and a bio-active agent, is provided. The product is prepared by making a dispersion of reversed vesicles in a suitable apolar vehicle, which vehicle is subsequently removed. In admixture with one or more excipients the product can be incorporated in compositions.
    Type: Application
    Filed: November 26, 2008
    Publication date: November 26, 2009
    Applicant: YAMANOUCHI EUROPE B.V.
    Inventors: Tom de Vringer, Hinderikus Marius Mollee
  • Publication number: 20040254352
    Abstract: Lipid conjugates of a poly-(amino acid), a poly-(amino acid derivative) or a poly-(amino acid analogue), such as poly-[N-(2-hydroxyethyl)-glutamine](PHEG), are provided.
    Type: Application
    Filed: July 23, 2004
    Publication date: December 16, 2004
    Inventors: Josbert Maarten Metselaar, Wilhelmus Everardus Hennick, Tom De Vringer, Leonardus Wilhelmus Theodorus De Boer, Christien Oussoren, Gerrit Storm, Peter Bruin
  • Publication number: 20040241222
    Abstract: Colloidal carrier compositions, comprising an active agent and a lipid conjugate of a poly-(amino acid), a poly-(amino acid derivative) or poly-(amino acid analogue), such as poly-[N-(2-hydroxyethyl)-glutamine] (PHEG), are provided.
    Type: Application
    Filed: June 17, 2004
    Publication date: December 2, 2004
    Inventors: Josbert Maarten Metselaar, Wilhelmus Evardus Hennick, Tom De Vringer, Leonardus Wilhelmus Theodorus De Boer, Christien Oussoren, Gerrit Storm, Peter Bruin
  • Patent number: 5904932
    Abstract: An aqueous suspension of solid lipoid nanoparticles, comprising at least one lipid and preferably also at least one emulsifier, for topical application to the body, is provided. The solid lipoid nanoparticles have a mean particle size of between 50-1000 nm and their concentration is between 0.01-60 wt %, by weight of the suspension. Also topical preparations, comprising said suspension of solid lipoid nanoparticles, are provided. A medicament can be incorporated into the continuous phase of the suspension or in a vehicle, which is added to said suspension.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: May 18, 1999
    Assignee: Yamanouchi Europe B.V.
    Inventor: Tom De Vringer
  • Patent number: 5667800
    Abstract: An aqueous suspension of solid lipoid nanoparticles, comprising at least one lipid and preferably also at least one emulsifier, for topical application to the body, is provided. The solid lipoid nanoparticles have a mean particle size of between 50-1000 nm and their concentration is between 0.01-60 wt %, by weight of the suspension. Also topical preparations, comprising said suspension of solid lipoid nanoparticles, are provided. A medicament can be incorporated into the continuous phase of the suspension or in a vehicle, which is added to said suspension.The invention further provides manufacturing methods for the aqueous suspension of solid lipoid nanoparticles as well as for preparations comprising such suspension.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: September 16, 1997
    Assignee: Yamanouchi Europe B.V.
    Inventor: Tom De Vringer